Dyadic International, Inc. (DYAI) News
Track canonical SquawkNews coverage tagged to DYAI, Dyadic International, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 10 indexed stories across 9 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Dyadic International Disclosed Failure to Satisfy a Continued Listing Rule or Standard
On September 25, 2026, the company received two Nasdaq deficiency notices for failing to meet the $1.00 minimum bid price under Rule 5550(a)(2) and the $35 million Market Value of Listed Securities under Rule 5550(b)(2).
NEWS | Sep 25, 2026, 09:36 PM UTC
L
Q3 Virtual Investor Summit Presentations Now Available On Demand
Q3 Virtual Investor Summit Presentations Now Available On Demand
EQUITY | Aug 31, 2026, 10:15 PM UTC
L
DYAI: Commercial-stage protein platform drives growth with new products, partners, and recurring revenues
DYAI: Commercial-stage protein platform drives growth with new products, partners, and recurring revenues
EQUITY | Aug 26, 2026, 08:36 PM UTC
L
DYAI: Commercialization and recurring revenue accelerate as partnerships and product launches expand
DYAI: Commercialization and recurring revenue accelerate as partnerships and product launches expand
EQUITY | Aug 26, 2026, 08:11 PM UTC
L
Dyadic International secures $2.9 million in offering
Dyadic International, Inc. says it secured $2.9 million through a registered direct offering and concurrent private placement.
MNA | Aug 13, 2026, 12:02 PM UTC
L
DYAI Announces Q2 2026 Financial Results
DYAI announces second quarter 2026 financial results
EARNINGS | Aug 12, 2026, 12:30 PM UTC
M
Dyadic Expands Non-Animal Dairy Pipeline
Dyadic signs new development agreement
EQUITY | Aug 04, 2026, 11:25 AM UTC
L
DYAI - Dyadic to Report Q2 2026 Financial Results and Host Conference Call on Wednesday August 12, 2026
DYAI - Dyadic to Report Q2 2026 Financial Results and Host Conference Call on Wednesday August 12, 2026
EARNINGS | Aug 03, 2026, 08:30 PM UTC
L
DYAI Dyadic international - develops c1 cell lines and manufactures bundibugyo ebolavirus antigens within 15 days - Delivers c1-produced bun
DYAI Dyadic international - develops c1 cell lines and manufactures bundibugyo ebolavirus antigens within 15 days - Delivers c1-produced bundibugyo ebolavirus antigens to FBS and Scripps for preclinical evaluation
EQUITY | Jul 28, 2026, 12:31 PM UTC
L
DYAI Dyadic international - expands Bio-industrial pipeline with new proprietary industrial enzyme program - To pursue commercialization thr
DYAI Dyadic international - expands Bio-industrial pipeline with new proprietary industrial enzyme program - To pursue commercialization through sales, collaborations, manufacturing, and licensing
EQUITY | Jul 16, 2026, 12:01 PM UTC